Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: Possible substrate for diastolic dysfunction

Journal of Cardiovascular Magnetic Resonance

Volumn 9, Issue 6, 2007, Pages 907-913

  Raman, Subha V ^a,c   Sparks, Elizabeth A ^a   Baker, Peter M ^b   McCarthy, Beth ^a   Wooley, Charles F ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cardiomyopathy; Genetics; Lamin; Magnetic resonance imaging

Indexed keywords

GADOLINIUM; LAMIN A; LAMIN C;

ADULT; ARTICLE; AUTOPSY; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENOTYPE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM; HUMAN; IMAGE ENHANCEMENT; IN VIVO STUDY; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIGREE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTOLE; TREATMENT CONTRAINDICATION;

ADULT; AUTOPSY; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; DIASTOLE; FEMALE; FIBROSIS; GENOTYPE; HUMANS; LAMIN TYPE A; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING, CINE; MALE; MUTATION; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 36849026789     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640701693733     Document Type: Article

References (21)

1. Graber H, Unverferth D, Baker P, Ryan J, Baba N, Wooley C. Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation 1986;74:21-35.
2. Sparks EA, Graber H, Boudoulas D, Nelson S, Baker III P, Wooley CF. Atrial myopathy and atrial fibrillation: phenotypes in heritable cardiac conduction andmyocardial disease. European Heart Journal Supplements 2000;2:K79-K90.
3. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB, 3rd, Cody RJ, Fishman MC, et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 1994;7:546-51.
4. Nelson SD, Sparks EA, Graber HL, Boudoulas H, Mehdirad AA, Baker P, Wooley C. Clinical characteristics of sudden death victims in heritable (chromosome 1p1- 1q1) conduction and myocardial disease. J Am Coll Cardiol 1998;32:1717-23.
5. McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59.
6. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7.
7. Jelicks L, Shirani J, Wittner M, Chandra M, Weiss L, Factor S, Bekirov I, Braunstein V, Chan J, Huang H, Tanowitz H. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease. Am J Trop Med Hyg 1999;61:207-214.
8. Varghese A, Pennell D. Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart 2004;90:e59-.
9. Carr JC, Simonetti O, Bundy J, Li D, Pereles S, Finn JP. Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. Radiology 2001;219:828-34.
10. Chung YC, Vargas J, Simonetti OP, Kim R, Judd RM. Infarct imaging in a single heart-beat. Journal of Cardiovascular Magnetic Resonance 2002:(abstract).
11. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-83.
12. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
13. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, Kalil-Filho R, Mady C, Meneghetti JC, Lima JA, Ramires JA. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.
14. Tandri H, Saranathan M, Rodriguez E, Martinez C, Bomma C, Nasir K, Rosen B, Lima J, Calkins H, Bluemke D. Noninvasive detection ofmyocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98-103.
15. Smith GC, Kinali M, Prasad SK, Bonne G, Muntoni F, Pennell DJ, Nihoyannopoulos P. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2006;8:723-30.
16. Östlund C, Worman H. Nuclear envelope proteins and neuromuscular diseases. Muscle and Nerve 2003;27:393-406.
17. Charniot J, Pascal C, Bouchier C, Sébillon P, Salama J, Duboscq-Bidot L, Peuchmaurd M, Desnos M, Artigou J, Komajda M. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype. Human Mutation 2003;21:473-481.
18. Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 2006;86:967-1008.
19. Rankin J, Ellard S. The laminopathies: a clinical review. Clin Genet 2006;70:261-74.
20. Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Sclesi L, Baldini E, Gavazzi A, Tavazzi L. Autosomal dominant dilated cardiomyopathy with atriventricular block: A lamin A/C defect-related disease. J Am Coll Cardiol 2002;39:981-990.
21. Arenal A, del Castillo S, Gonzalez-Torrecilla E, Atienza F, Ortiz M, Jimenez J, Puchol A, Garcia J, Almendral J. Tachycardia-Related Channel in the Scar Tissue in Patients With Sustained Monomorphic Ventricular Tachycardias: Influence of the Voltage Scar Definition. Circulation 2004;110:2568-2574.